Loading…
We use essential cookies (authentication, your saved goals/stack) by default. With your permission we’ll also enable privacy-respecting analytics (Vercel Web Analytics, anonymous load-time metrics) and error-replay diagnostics (Sentry — DOM snapshots only when an error fires) so we can fix bugs faster. Learn more about cookies
Head-to-head evidence comparison — which supplement is right for you?
Berberine vs Vitex: Berberine has the stronger overall evidence (7.5 vs 7/10); they're alternatives for cycle & hormonal symptoms — the best pick depends on your goals. Take the 60-second quiz for a pick tailored to your goals.
Berberine wins 2 of 3 categories. Both are solid choices — the best pick depends on your specific goals.
Verdict
Likely helps
8 of 8 studies with measurable effects showed benefit.
Top outcomes
Verdict
Likely helps
3 of 4 studies with measurable effects showed benefit.
Top outcomes
Shared outcomes (1)
Outcomes where both Berberine and Vitex have evidence — compare verdict strength side-by-side.
500mg 2-3x daily (1000-1500mg total)
With meals, Split into 2-3 doses
Berberine HCl capsules
20-40mg extract (standardized to 0.5% agnuside). The cited trials used 20 to 30 mg of extract a day.
Morning, Consistently at same time daily
Standardized extract (0.5% agnuside or 0.6% aucubin)
and 3 more not shown
and 1 more not shown
4-12 weeks
8-12 weeks
First 2 weeks
If on diabetes medications
1-3 cycles
2-3 cycles
1-2 cycles
Clinical Efficacy of Curcumin, Resveratrol, Silymarin, and Berberine on Cardio-Metabolic Risk Factors Among Patients With Type 2 Diabetes Mellitus: A Systemic Review and Bayesian Network Meta-Analysis
Phytotherapy research : PTR (2025) · Meta analysis · n=1337
For HbA1c, silymarin was more effective than resveratrol (MD -2.08, 95%Cl -3.50 to -0.72) (P < 0.05).
Effects of berberine and barberry on selected inflammatory biomarkers in adults: A systematic review and dose-response meta-analysis of randomized clinical trials
Phytotherapy research : PTR (2023) · Meta analysis · n=1600
In addition, the non-linear analysis showed a significant lowering effect of berberine/barberry on IL-6 and TNF-α levels in doses <1000 mg/day and less than 5 weeks of intervention.
Berberine Ursodeoxycholate for the Treatment of Type 2 Diabetes: A Randomized Clinical Trial
JAMA network open (2025) · Rct · n=113
The study included 113 patients with T2D (mean [SD] age, 54.3 [10.6] years; 72 male [63.7%]) who were randomized.
Vitex agnus-castus in premenstrual syndrome: A meta-analysis of double-blind randomised controlled trials
Complementary Therapies in Medicine (2019) · Meta analysis · n=520
Out of 21 clinical trials, three double-blind placebo-controlled studies (520 females) met the reporting criteria, testing the characterised extracts Ze 440 and BNO 1095.
Herbal medicine for depression and anxiety: A systematic review with assessment of potential psycho-oncologic relevance
Phytotherapy research : PTR (2018) · Systematic review
Overall, 45% of studies reported positive findings with fewer adverse effects compared with conventional medications.
A Critical Approach to Evaluating Clinical Efficacy, Adverse Events and Drug Interactions of Herbal Remedies
Phytotherapy research : PTR (2016) · Review
A critical narrative review of published systematic reviews and meta-analyses of herbal remedies. It pools no data of its own.
The 1,000 mg point is a placebo-controlled trial of berberine 1.0 g daily for 3 months in 116 people with type 2 diabetes, where HbA1c fell from 7.5% to 6.6% and fasting glucose fell more than on placebo (PMID 18397984). The 1,500 mg point is two trials of 500 mg three times daily: one in 36 people with new type 2 diabetes where glucose fell with no significant difference from metformin in this small pilot, with transient stomach side effects in 34.5% (PMID 18442638), and a placebo-controlled pilot in 34 people with prediabetes where HbA1c fell from 6.40% to 5.43% (PMID 37679692). No trial compared doses, so the curve is flat between them and no optimal dose is set. Lower doses were not tested for glucose in any cited trial.
The points come from one dose-finding RCT of the Ze 440 extract in 162 women with PMS over three cycles, at 8, 20 or 30 mg a day (PMID 23022391). Total symptom scores improved more at 20 mg than with placebo or 8 mg, and 30 mg did not improve them further than 20 mg, so the curve is flat above 20 mg. All three doses were well tolerated, and no higher dose of this extract was tested. A meta-analysis of 3 trials of characterised extracts (Ze 440, BNO 1095; 520 women) found Vitex users 2.57 times more likely to remit (PMID 31780016). A broader pooled effect was large but rated explorative because of high risk of bias, heterogeneity (I² 91%) and publication bias (PMID 28237870).
AI-estimated from published studies. Interpret as directional guidance.
Berberine has a higher evidence score (7.5/10 vs 7/10) and wins in 2 of 3 categories.
For cycle & hormonal symptoms, Vitex has a higher relevance score (85 vs 40).
No documented interaction was found in the data searched. This does not establish that this exact combination is safe.
The honest tier list — proven staples vs situational vs mostly marketing. The hub the other guides feed into.
Which supplements clash with blood thinners, thyroid meds, antibiotics & more — and what to do.
What genuinely lowers LDL/triglycerides — and why "red yeast rice" is a statin in disguise.
Berberine, inositol, magnesium vs the cinnamon/chromium hype — and the med-interaction warning.
The right pick depends on your goals. Answer a few quick questions for a personalised recommendation — or dig into the full evidence on each.